RO7515629

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7515629, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]